Novartis AG (NVSEF) cash flow statement

NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30

$146.46+2.56 (+1.78%)

Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –

Novartis AG cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q2 2025 2025-06-30	Q2 2024 2024-06-30	Q2 2023 2023-06-30	Q2 2022 2022-06-30	Q2 2021 2021-06-30	Q2 2020 2020-06-30	Q2 2019 2019-06-30	Q2 2018 2018-06-30	Q2 2017 2017-06-30
Stock-Based Compensation	267	267	257	222	204	185	199	174	155	–
Change in Accounts Receivable	-256	-167	-501	-447	-413	–	–	–	–	–
Change in Inventory	30	-44	-18	-185	-194	–	–	–	–	–
Change in Accounts Payable	-184	-143	-142	73	11	–	–	–	–	–
Operating Cash Flow	5,882	6,664	4,875	3,576	3,755	4,132	3,961	3,111	3,942	–
Capital Expenditures	-321	-331	-260	-225	-257	-321	-238	-279	-257	-332
Acquisitions	-23	-127	–	–	–	–	–	–	–	–
Sale of Property, Plant & Equipment	26	1.00	37	4.00	13	19	1.00	648	6.00	7.00
Investing Cash Flow	-3,105	-2,243	-3,207	-1,053	-11,628	97	-425	-474	4,325	-337
Share Repurchases	-1,199	-2,714	-1,616	-2,957	-2,714	-703	-9.00	-2,368	-599	-1,876
Financing Cash Flow	-2,020	-5,213	-3,200	-3,637	-2,302	-2,939	-2,185	-28	-1,530	-3,012
Foreign Exchange Rate Adjustments	-18	382	-34	-1.00	-52	26	38	76	-104	51
Net Change in Cash	739	-410	-1,566	-1,115	-10,227	1,316	1,389	3,184	6,633	284
Free Cash Flow	5,561	6,333	4,615	3,351	3,498	3,811	3,723	2,832	3,685	–
Income Taxes Paid	398	675	473	973	606	409	303	560	501	467

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 31.0%

Financial strength

Current ratio: 0.86
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 24.0%

Valuation

P/E ratio: 20.5
Price to sales: –
Price to book: 6.73
Dividend yield: –

See a number that looks wrong?